GME — Geratherm Medical AG Cashflow Statement
0.000.00%
Last trade - 00:00
- €22.36m
- €20.02m
- €25.85m
- 82
- 70
- 27
- 64
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.558 | 0.29 | 1.9 | 0.333 | 1.08 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 1.03 | 0.402 | 1.77 | 0.396 | 0.844 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1 | -0.712 | -1.09 | -1.42 | -0.618 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1.51 | 1.54 | 3.92 | 0.917 | 2.79 |
Capital Expenditures | -4.23 | -2.32 | -2.78 | -1.3 | -2.74 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 1.38 | -2.17 | -1.01 | 1.3 | 1.97 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2.85 | -4.49 | -3.79 | 0.003 | -0.767 |
Financing Cash Flow Items | -0.167 | 0 | 0.014 | -0.025 | -0.006 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2.25 | 1.72 | 0.684 | -3.52 | 4.35 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3.45 | -1.22 | 0.716 | -2.59 | 6.42 |